Bruker Stock Performance
| BRKR Stock | USD 57.95 0.43 0.74% |
The firm shows a Beta (market volatility) of 0.89, which signifies possible diversification benefits within a given portfolio. Bruker returns are very sensitive to returns on the market. As the market goes up or down, Bruker is expected to follow. At this point, Bruker has a negative expected return of -0.16%. Please make sure to confirm Bruker's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Bruker performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Bruker has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's forward-looking signals remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors. ...more
Actual Historical Performance (%)
One Day Return (0.74) | Five Day Return 1.38 | Year To Date Return (19.85) | Ten Year Return 198.71 | All Time Return 151.3 |
Forward Dividend Yield 0.0035 | Payout Ratio 0.0612 | Forward Dividend Rate 0.2 | Dividend Date 2024-12-16 | Ex Dividend Date 2024-12-02 |
1 | Disposition of 10000 shares by Rosenthal Bob of Bruker at 24.0 subject to Rule 16b-3 | 09/06/2024 |
| Bruker dividend paid on 16th of September 2024 | 09/16/2024 |
2 | Biognosys Enters Reselling Agreement for Spectronaut Proteomics Software with Leading Provider of Mass Spectrometry Systems | 09/18/2024 |
3 | 60.5 Billion Proteomics Industry Forecast Report, 2029, Featuring Strategic Analysis of 25 Key Players - Thermo Fisher Scientific, Agilent Technologies, Merck, ... | 10/09/2024 |
4 | Earnings Tell The Story For Bruker Corporation | 10/25/2024 |
5 | Bruker Non-GAAP EPS of 0.60, revenue of 864.4M | 11/05/2024 |
6 | Bruker stock price target cut, hold rating sustained on Q3 performance | 11/06/2024 |
7 | BRKR Misses on Q3 Earnings, Cuts 24 View, Stock Up in Aftermarket | 11/07/2024 |
8 | Bruker Corp Shares Gap Down to 58.57 on Nov 8 | 11/08/2024 |
9 | Brukers Problems Go Beyond Weak Profit - Yahoo Finance | 11/14/2024 |
10 | Acquisition by Frank Laukien of 69866 shares of Bruker at 49.82 subject to Rule 16b-3 | 11/18/2024 |
| Begin Period Cash Flow | 648.7 M |
Bruker |
Bruker Relative Risk vs. Return Landscape
If you would invest 6,572 in Bruker on September 2, 2024 and sell it today you would lose (777.00) from holding Bruker or give up 11.82% of portfolio value over 90 days. Bruker is currently does not generate positive expected returns and assumes 2.6544% risk (volatility on return distribution) over the 90 days horizon. In different words, 23% of stocks are less volatile than Bruker, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bruker Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bruker's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bruker, and traders can use it to determine the average amount a Bruker's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0611
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BRKR |
Estimated Market Risk
| 2.65 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.16 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bruker is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bruker by adding Bruker to a well-diversified portfolio.
Bruker Fundamentals Growth
Bruker Stock prices reflect investors' perceptions of the future prospects and financial health of Bruker, and Bruker fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bruker Stock performance.
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0483 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 11.05 B | ||||
| Shares Outstanding | 151.6 M | ||||
| Price To Earning | 67.10 X | ||||
| Price To Book | 4.86 X | ||||
| Price To Sales | 2.71 X | ||||
| Revenue | 2.96 B | ||||
| Gross Profit | 1.31 B | ||||
| EBITDA | 599 M | ||||
| Net Income | 427.2 M | ||||
| Cash And Equivalents | 733.6 M | ||||
| Cash Per Share | 4.95 X | ||||
| Total Debt | 1.38 B | ||||
| Debt To Equity | 1.20 % | ||||
| Current Ratio | 2.55 X | ||||
| Book Value Per Share | 11.92 X | ||||
| Cash Flow From Operations | 350.1 M | ||||
| Earnings Per Share | 2.07 X | ||||
| Market Capitalization | 8.79 B | ||||
| Total Asset | 4.25 B | ||||
| Retained Earnings | 2.32 B | ||||
| Working Capital | 962.1 M | ||||
| Current Asset | 1.23 B | ||||
| Current Liabilities | 554.6 M | ||||
About Bruker Performance
Assessing Bruker's fundamental ratios provides investors with valuable insights into Bruker's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Bruker is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 243.54 | 271.57 | |
| Return On Tangible Assets | 0.13 | 0.13 | |
| Return On Capital Employed | 0.14 | 0.09 | |
| Return On Assets | 0.10 | 0.11 | |
| Return On Equity | 0.31 | 0.33 |
Things to note about Bruker performance evaluation
Checking the ongoing alerts about Bruker for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bruker help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bruker generated a negative expected return over the last 90 days | |
| Bruker is unlikely to experience financial distress in the next 2 years | |
| Over 80.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from MacroaxisInsider: Acquisition by Frank Laukien of 69866 shares of Bruker at 49.82 subject to Rule 16b-3 |
- Analyzing Bruker's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bruker's stock is overvalued or undervalued compared to its peers.
- Examining Bruker's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bruker's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bruker's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bruker's stock. These opinions can provide insight into Bruker's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Bruker Stock Analysis
When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.